Michael Porter is an economist, researcher, author, advisor, speaker and University Professor at Harvard Business School.

Since the early 2000s, Michael Porter has devoted considerable attention to the economics of health care and introduced the core concepts for reorganizing health care delivery organizations, measuring patient outcomes, understanding the actual cost of care by medical condition, designing value-based reimbursement models, and integrating multi-location health systems, among others.

He has been strategy advisor to leading U.S. and international companies, served on Fortune 500 public boards, and played an active role in U.S. economic policy at the federal and state levels. He has worked with heads of state from around the world on economic development strategy.

Michael Porter has founded or co-founded four non-profit organizations growing out of his scholarly work: The Initiative for a Competitive Inner City, the Center for Effective Philanthropy, FSG, and the International Consortium for Health Outcomes Measurement (ICHOM).

The patient perspective can form an integral bridge between effective health service planning and delivery. As a qualified teacher with over 8 years' experience in the Health sector and specializing in maternity care, Tessa brings a unique ability to work in partnership with health organizations and their consumers through advising, advocating, presenting and educating.

Tessa develops, utilizes and implements a wide range of consumer engagement strategies, plays an active role as a consumer representative, and is the Founder and Principal Consultant of One Mother to Another.

Tessa designs and facilitates consumer engagement projects, such as the 'Birthing Stories' project and educational workshops for consumers and professionals. She has developed numerous educational resources which include videos, webinars and literature. Tessa is published in the Australian Midwifery News and her educational video, 'The Importance of Patient Perspective in Outcome Measurement', premiered in Utrecht, the Netherlands and has since been shown across Europe and Australia.

Jeffrey Balser, is President and CEO of Vanderbilt University Medical Center and Dean, Vanderbilt University School of Medicine. Previously, he practiced cardiac anesthesiology, ICU medicine, and led an NIH-funded research program aimed at the genetics of cardiac rhythm disorders at Johns Hopkins. He was Associate Dean for Physician Scientist Development, and Chair of the Department of Anesthesiology at Vanderbilt University Medical Center (VUMC). He became the medical center's chief research officer in 2004. Dr. Balser was elected to the National Academy of Medicine, and later named Dean of Vanderbilt's School of Medicine. In 2009, he was also appointed Vice Chancellor for Health Affairs. As the first President and CEO of VUMC he serves, and participates on, an independent 11-member board of directors, and continues to serve as dean of the Vanderbilt University School of Medicine. Dr. Balser also serves on the boards of Tulane University and the Center for Medical Interoperability.

Ben Harder oversees U.S. News & World Report's portfolio of data-driven patient decision-support tools. Freely available at usnews.com/health, these tools include the Best Hospitals rankings and ratings, nursing home ratings, and more than 850,000 searchable online profiles of individual physicians. Harder is a healthcare journalist whose work has appeared in BMJ, JAMA, the Chicago Tribune, the Los Angeles Times, Science News, USA Today, the Washington Post and other publications, as well as the anthology Best American Science Writing 2005. He earned a bachelor's degree from Harvard University and completed a journalism fellowship at the CDC. He has been an editor at U.S. News since 2007.

Dr. Tom Lee is Chief Medical Officer of Press Ganey, and an internist and cardiologist, who practices at Brigham and Women's Hospital in Boston. He is a Professor of Medicine, part time, at Harvard Medical School and Professor of Health Policy and Management at the Harvard School of Public Health. Tom is a member of the Special Medical Advisory Group of the Veterans Administration, the Panel of Health Advisors of the Congressional Budget Office and the Editorial Board of The New England Journal of Medicine. He is the author of more than 260 academic articles and three books, Chaos and Organization in Health Care; Eugene Braunwald and the Rise of Modern Medicine; and An Epidemic of Empathy in Healthcare.

Susan Sherry is the Deputy Director at Community Catalyst and is responsible for overseeing a broad range of projects, including state-based technical assistance programs and issue campaigns as well as national strategy. She has 10 years human service agency experience prior to her health advocacy work. Susan represents Community Catalyst on the Health Care Transformation Task Force Board of Directors, the Center for Medicare and Medicaid Services Health Care Payment Learning and Action Network (LAN) Guiding Committee and the Massachusetts Attorney General Advisory Task Force on Community Benefits. Prior to joining Community Catalyst, Susan was the founding Executive Director of Health Care For All in which she represented consumer interests in negotiations around the 1986 Massachusetts universal health care law, hospital free care, and insurance market reforms. She also directed the state technical assistance program at Families USA. Susan has been an instructor at the Harvard Chan School of Public Health since 2000 teaching community organizing where her work was acknowledged with a citation for teaching excellence in 2015.

Mr. Gagne has been the Lead Organizer for the Rhode Island Organizing Project (RIOP) since 2005. He is currently coordinating RIOP's multiyear initiative to improve health care outcomes and expand home & community based services for low income seniors and disabled adults. Prior to his work at RIOP, Mr. Gagne served as the Lead Organizer for the Essex County Community Organization (ECCO) in Lynn, Massachusetts and the United Interfaith Action (UIA) in Fall River, Massachusetts. During his tenure at ECCO and UIA, Mr. Gagne coordinated organizing campaigns around adult education, affordable housing, health care, and programs for children.

Jane Hash is a founding member of the Ohio Consumer Voice for Integrated Care (OCVIC), a project of Universal Health Care Action Network (UHCAN). This group of dually-eligible Consumers provides peer-to-peer support and communicates regularly with MCOs, Ombudsman, the Department of Medicaid and other organizations to help improve the Consumer experience and encourage Consumer engagement.

Ms. Hash is a co-founding Director of the nonprofit organization, Classy Little Fashions Foundation. The mission of CLFF is to support individuals with physical disabilities who have asymmetrical body types by developing and supporting venues that make age appropriate fashionable clothing accessible; promote positive body image, healthy living, and healthy expressions of sexuality; and, educate community about the unique and severe fundamental challenges of this minority population.

Ms. Hash is a student of Naturopathy and has completed Herbalist, completed the Certified Natural Health Professional program recently began taking classes through The Medical Cannabis Institute.

Paul Henderson is a Director at KPMG LLP and leads the firm's Health Data and Analytics business in the UK. Using KPMG's considerable international experience of transforming healthcare, Paul leads a team that supports KPMG's work on audit, care system redesign and place-based planning, new models of care, provider financial improvement, regulation and many other areas through the delivery of services and the development of analytics software. Data and Analytics is also a business in its own right and Paul delivers and leads management consulting engagements in the UK and abroad. He is also the UK lead on Big Data in health.

Dr. Hazelzet has a long clinical experience as Pediatric Intensivist, and Associate-Professor in Pediatrics. He gradually moved to the field of information and quality, first in the position of chief medical information officer of Erasmus MC, later as professor in Health Care Quality & Outcome. He is the clinical lead of the Erasmus MC Value-Based Health Care Program and the shift towards a more Patient-Centered Care.

Paul leads four major work streams for NHS Improvement's Costing Transformation Programme in England. These are 'transitioning to a single national cost collection', 'uses of cost data', 'improving data quality' and 'making best use of technology'. Paul led the rollout of the National PLICS Portal in England, which will give all hospitals access to patient-level cost and outcome data. Paul has a talent and passion for turning data into meaningful information and using this to affect how the business operates. Paul has worked in senior roles at the University Hospitals Bristol, Audit Commission, Lloyds TSB and Revlon PLC.

Dr. Niazi is a consultant in the Department of Psychiatry at Mayo Clinic Florida and Assistant Professor of Psychiatry at Mayo Medical School. He primarily works with Cancer and Transplant Centers. He is board certified by the American Board of Psychiatry and Neurology in both Psychiatry and in Psychosomatic Medicine. He has Specialty Certificate in Psychiatry from the Royal College of Physicians and surgeons of Canada and is a Fellow of Royal College of Physicians and Surgeons of Canada. He is also a Distinguished Fellow of the American Psychiatric Association and a fellow of the Academy of Psychosomatic Medicine. He has been working with Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery conducting Health Services Research. He is interested in clinical-informatics, healthcare delivery models, implementing patient reported outcomes and understanding impact of psychiatric conditions on economic, clinical and humanistic outcomes in cancer and transplant patients.

Dr. Damon Ramsey is a practicing physician, clinical instructor, and CEO/Founder of InputHealth, a digital health company which has re-envisioned health records as a vehicle for patient engagement. InputHealth's electronic data capture platform is utilized by UBC, Mayo Clinic, University of Texas-Austin among other institutions, and is rapidly gaining traction across North America as a leading solution to power value-based care delivery.

Dr. Rogers-Vizena is a pediatric plastic and craniofacial surgeon at Boston Children's Hospital and an Assistant Professor at Harvard Medical School. She is a graduate of the University of Pittsburgh School of Medicine, completed her Plastic Surgery residency at the University of Wisconsin, and a Craniofacial Surgery fellowship at Boston Children's Hospital. Her current research parallels her clinical interests, with an emphasis on surgical simulation and cleft lip and palate outcomes. As part of that work, Dr. Rogers-Vizena is Scientific Co-Chair for the International Consortium for Health Outcomes Measurement Cleft Lip and Palate benchmarking program. In addition, she is highly engaged in the Boston Children's Hospital Simulator Program and holds the appointments of Associate Clinical Director for Plastic and Oral Surgery and Special Effects and Materials Science.

David Lansky, PhD, is the president and Chief Executive Officer of the Pacific Business Group on Health (PBGH). Lansky is the vice chair of the Health Care Transformation Task Force and is on the Guiding Committee of the HHS Learning and Action Network, the Congressional Budget Office Health Advisors Panel, and the Board of the Alliance for Health Reform.

Previously, Lansky was senior director of the Health Program at the Markle Foundation (NY), and he established the Foundation for Accountability (FACCT). He was a senior policy analyst for the Jackson Hole Group and led the Center for Outcomes Research and Education at Oregon-based Providence Health System. Lansky has served as a board member or advisor to numerous health care programs, including the National Quality Forum, federal Health IT Policy Committee, Catalyst for Payment Reform, Joint Commission, National Patient Safety Foundation, Leapfrog Group, and the Medicare Beneficiary Education Advisory Panel.

Ian Forde is a Senior Policy Analyst in the Health Division at the OECD, and leads the programme for Health Systems Quality and Outcomes. He has led over fifteen OECD Health System Reviews, including Colombia, Mexico, Japan, Australia and the United Kingdom. He previously worked as a policy advisor in the Ministry of Health, Bogota, and in the Prime Minister's Strategy Unit, London. He was a member of the secretariat of the WHO Global Commission on Social Determinants of Health and has published in the Lancet, the BMJ, the American Journal of Public Health and several other peer-reviewed journals.

Dr. Fox is the associate chief medical officer for Priority Health. Dr. Fox is responsible for technology assessment and medical policy development, and innovative programming. These include pay-for-value contracting, integrated specialty pharmacy management, behavioral health initiatives, surgical optimization initiatives, community-based palliative care, and oncology medical home programs.

Prior to joining Priority Health, Dr. Fox was the chief medical officer at Physicians Plus Insurance. He has also worked for the Indian Health Service and with the Epidemic Intelligence Service at the Centers for Disease Control and Prevention in Atlanta.

Dr. Fox has written and lectured on value-based benefit design, the impact of genomics and proteomics on future medical practice, clinical outcomes-based contracting, and shared decision making in reducing variations in surgery rates, and the role of behavioral economics on health decisions and outcomes.

Dr. Safran is chief performance measurement and improvement officer and senior vice president, enterprise analytics at Blue Cross Blue Shield of Massachusetts (BCBSMA). Dr. Safran was among the lead developers of the BCBSMA Alternative Quality Contract (AQC), a provider contract model launched in 2009 with the twin goals of improving quality and outcomes while significantly slowing spending growth. Dr. Safran also retains an active academic practice, as a faculty member in the Department of Medicine at Tufts University School of Medicine.

Dr. Safran's advisory roles on national and local quality measurement include work with the the Centers for Medicare and Medicaid Services (CMS), the National Quality Forum (NQF), the American Board of Internal Medicine (ABIM), the National Committee for Quality Assurance (NCQA), and the Massachusetts State Quality Advisory Council (SQAC). She serves on the Boards of Directors for a number of charitable and academic organizations.

David Cella is the Ralph Seal Paffenbarger Professor and Chair of the Department of Medical Social Sciences at the Northwestern University Feinberg School of Medicine. He studies questions regarding quality of life measurement in clinical trials, cross-cultural equivalence of quality of life measurement, efficacy of psychosocial interventions in chronic illness, and medical outcomes research. Dr. Cella has studied quality of life as a scientific enterprise, bringing the voice of the patient into consideration of value and opportunities for improvement. Dr. Cella developed and is continually refining the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System for outcome evaluation in patients with chronic medical conditions. He was steering committee chair and principal investigator of the statistical coordinating center for the NIH Roadmap Initiative to build a Patient Reported Outcome Measurement Information System (PROMIS) and is currently the principal investigator of the PRO Core of the Environmental Influences on Child Health Outcomes (ECHO) NIH initiative.

Dr. Baumhauer is Professor and Associate Chair of Department of Orthopaedics at the University of Rochester. In addition to being a clinically active surgeon, she is the Director of Patient Reported Outcomes (PROMIS) for the UR Health Care System and a board member of Accountable Health Partners, ACO for the Rochester Region.

Dr. Baumhauer is the past president of the American Board of Orthopaedic Surgery, American Orthopaedic Foot and Ankle Society (AOFAS), Eastern Orthopaedic Association and sits on the board of the PROMIS Health Organization. Her research interest focuses on the clinical translation patient reported outcomes.

Sean Tunis is President and Chief Executive Officer of the Center for Medical Technology Policy in Baltimore, Maryland. CMTP is an independent, non-profit organization that provides a neutral platform for multi-stakeholder collaborations that promote high value innovation by improving the quality, relevance, and efficiency of clinical research.

Previously, Dr. Tunis was the Director of the Office of Clinical Standards and Quality and Chief Medical Officer at the Centers for Medicare and Medicaid Services (CMS). He also served as the Director of the Health Program at the Congressional Office of Technology Assessment and as a health policy advisor to the U.S. Senate Committee on Labor and Human Resources.

Dr. Tunis serves as Vice-President of Health Technology Assessment International, a member of the Health Sciences Policy Council for ISPOR and on several other public and private governing and advisory boards.

Elise Berliner is the Director of the Technology Assessment Program at the Agency for Healthcare Research and Quality (AHRQ). The Technology Assessment program provides technology assessments to the Centers for Medicare & Medicaid Services (CMS) to inform Medicare coverage decisions and other policy issues. Prior to joining AHRQ, Dr. Berliner worked as a consultant to pharmaceutical and medical device companies on cost-effectiveness and outcomes research, technology assessment and reimbursement planning. Dr. Berliner also has several years of experience in research and development at a number of innovative medical technology companies. She was a Congressional Fellow at the Office of Technology Assessment.

Rachael Fleurence is the Executive Director for the Medical Device Innovation Consortium's (MDIC) National Evaluation System for health Technology (NEST) Coordinating Center. Under Dr. Fleurence's leadership, NESTcc strives to catalyze the timely, reliable, and cost-effective development of real-world evidence to enhance regulatory and clinical decision-making to improve patient outcomes. Dr. Fleurence joined MDIC from the Patient-Centered Outcomes Research Institute (PCORI), where she led the National Patient-Centered Clinical Research Network (PCORnet) program. A health economist and health services researcher by training, Dr. Fleurence has authored multiple peer-reviewed publications and has supported various health organizations in Board and Steering Committee roles.

Dr Pall Jonsson is Associate Director for Research and Development at UK's National Institute for Health and Care Excellence (NICE). He leads NICE's contribution to a portfolio of research projects which support NICE in adapting to policy developments in health and social care delivery. Pall has a doctorate degree in biochemistry and bioinformatics from University College London and has expertise in health technology assessments of drugs and diagnostics gained through his work at NICE.

Before joining NICE he gained research experience in academia, the not for-profit sector and the pharmaceutical industry. He sits on advisory boards of several international projects in the area of health technology assessment and evidence generation.

Paul G. Kluetz, M.D., is the Associate Director of Clinical Science in the Office of Hematology and Oncology Products (OHOP) and the Acting Associate Director of Patient Outcomes in the Oncology Center of Excellence at the U.S. Food and Drug Administration. Originally, he focused on genitourinary cancers and played a key role in the review of several important novel prostate cancer therapies. He later served as Acting Deputy Director of OHOP.

Dr. Kluetz has developed expertise in several areas of regulatory science and policy. In 2016, he took a permanent position as Associate Director of Clinical Science within the OHOP Immediate Office, and more recently has been assigned to the new Oncology Center of Excellence. He also serves as Director of the Oncology Program.

Dr. Kluetz continues to enjoy seeing patients and teaching medical house staff as an attending physician at the Georgetown University Hospital.

Dr Charlotte Roberts is Vice-President for Standardisation at the International Consortium for Health Outcomes Measurement (ICHOM) where she leads the development of all Standard Sets of outcomes that matter most to people with different medical conditions. She joined ICHOM as a Project Leader in 2014 leading the development of the Dementia, Older Person, and Inflammatory Bowel Disease Standard Sets. Prior to joining ICHOM, Charlotte trained in Medicine and International Health at University College London and worked as a doctor in Oxford before completing a NHS National Medical Director's Clinical Fellowship in Medical Leadership and Management at Public Health England in 2013-14.

Barbara Skerritt has almost 25 years' experience in cross-functional professional services outsourcing, including leadership, project oversight, staff management and sponsor interactions. Barbara's current role is as a senior project manager with ICON Clinical Research, where she is currently leading the GLobal Outcomes Benchmarking (GLOBE) Pilot Program. Barbara has presented at conferences and has published in peer-reviewed journals related to her area of expertise. Barbara is a member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and is a contributing member of the ISPOR COA /PRO Task Force Review Group (ISPOR).

Dr. Griggs is Professor in the Department of Medicine in the Division of Hematology/Oncology and in the Department of Health Management and Policy in the School of Public Health at the University of Michigan. She is a medical oncologist whose practice focuses on the care of patients with breast cancer.

Her research program focuses on quality of care and disparities in care, and patient-provider communication.

Dr. Griggs is the Program Director for the Michigan Oncology Quality Consortium, a statewide network of oncology practices that measures and improves oncology quality of care. She is also one of the editors of the Journal of Clinical Oncology.

Dr. Catarina R. Dolsten is the founder of CR Dolsten LLC where she specializes in executive leadership coaching, organizational development and change management consulting. Catarina has experience within healthcare, biotech, tech, non-profit and the financial services sectors, working with industry-leading institutions to deliver performance-based results. Catarina has experience from healthcare in Europe, United States and Africa. Catarina provides Leadership Assessment and Development; C-suite Executive Coaching;Team Training and Development; EQ, Diversity, Gender and Inclusion Training; Development of a Sustainable and Innovative Culture; Organizational Assessment and Strategic Planning for Growth; Change Management for Organizations in Transition.

Prior to executive coaching, Catarina developed and implemented programming to maximize organizational efficiency on a global scale, coaching and leading teams to achieve tangible results within maternal and child health, using methods such as e-health.

Catarina serves as a Board Director at Health Builders, a non-profit dedicated to leadership and management training for health centers in Africa.

Dr. Hazelzet has a long clinical experience as Pediatric Intensivist, and Associate-Professor in Pediatrics. He gradually moved to the field of information and quality, first in the position of chief medical information officer of Erasmus MC, later as professor in Health Care Quality & Outcome. He is the clinical lead of the Erasmus MC Value-Based Health Care Program and the shift towards a more Patient-Centered Care.

Gregory Katz is Director of Research & Innovation at ELSAN, a leading private hospital group with 2 million patients treated each year in 123 clinics in France. He is committed to the implementation of pilots designed to improve quality of care through Patient-Reported Outcomes. He is also Chaired Professor of Innovation Management & Healthcare Performance at the University Paris-Descartes Medical School. His publications focus on the economic impact of innovations in genomics and cell therapy. In 2009, he received the San Benedetto International Award for his achievements in bioethics and humanism. In 2015, he was invited to give the Public Health Grand Rounds Lecture at the UCLA Fielding School of Public Health.

Hannah Leslie is a Postdoctoral Research Fellow at the Harvard TH Chan School of Public Health and the Research Lead of Working Group 2: Measurement for the Lancet Global Health Commission on High-Quality Health Systems in the Sustainable Development Goal Era. Dr. Leslie received her MPH and PhD in Epidemiology from the University of California, Berkeley; her research interests include causal inference methods and the measurement of unobserved constructs such as health system quality and community social cohesion. Her current research focuses on measuring and improving health system quality in low-resource settings; she previously worked on HIV prevention and treatment programs in East Africa and South Africa.

Bistra Zheleva is the Vice President of International Programs at Children's HeartLink. She leads the direction and strategy of Children's HeartLink's capacity building work in pediatric cardiac care in the five countries the organization is currently involved in – Brazil, China, India, Malaysia and Vietnam, as well as explores growth opportunities globally. Previously, Bistra was responsible for the growth of the hospital partnerships at Children's HeartLink, strengthening and broadening the capacity building model, increasing the impact and reputation of the organization, and initiating the first health systems strengthening and advocacy initiatives. In collaboration with other staff and volunteers Bistra has fostered a number of strategic partnerships for the organization with other NGOs and local ministries and departments of health. She serves on the steering committee of the International Quality Improvement Collaborative for Congenital Heart Surgery in Developing World and is a founding member of a congenital heart patient and family leaders alliance.

Caleb Stowell is Enterprise-Director, Value Based Care at Providence St. Joseph Health, a large health system spanning 6 states in the Western United States. He leads their efforts to expand patient-reported outcome measurement and supports work bringing outcomes and cost data together to optimize the value of care. Prior to Providence, he helped found and lead the International Consortium for Health Outcomes Measurement (ICHOM), focusing on outcome standard development and stakeholder engagement. He received his medical degree at Harvard Medical School and was Senior Researcher at Harvard Business School for 6 years

Dr. Baumhauer is Professor and Associate Chair of Department of Orthopaedics at the University of Rochester. In addition to being a clinically active surgeon, she is the Director of Patient Reported Outcomes (PROMIS) for the UR Health Care System and a board member of Accountable Health Partners, ACO for the Rochester Region.

Dr. Baumhauer is the past president of the American Board of Orthopaedic Surgery, American Orthopaedic Foot and Ankle Society (AOFAS), Eastern Orthopaedic Association and sits on the board of the PROMIS Health Organization. Her research interest focuses on the clinical translation patient reported outcomes.

Dr. Wagle is the Associate Chief Quality Officer at Partners HealthCare, leading the system's efforts on Ambulatory Quality within the Division of Quality Safety and Value and the Center for Population Health. He is an expert on Patient-Reported Outcomes Measurement (PROMs), and a leading voice for the transition to more clinically relevant quality measures including the use of clinical registries for quality measurement. Dr. Wagle practices primary care at Brigham and Women's Primary Physicians.

Dr. Zimlichman is an internal medicine physician, a healthcare executive and researcher focused on assessing and improving health care quality and value, patient safety and patient engagement. Dr. Zimlichman is currently Deputy General Director, Chief Medical Officer and Chief Innovation Officer at Sheba Medical Center, Israel's largest hospital. Prior to this Dr. Zimlichman has held the position of Lead Researcher at Partners Health Care Clinical Affairs Department in Boston. Dr. Zimlichman is a graduate of the Harvard School of Public Health Executive Healthcare Management Master of Science program and has earned his MD at the Technion Israel Institute of Technology.

Pieter de Bey is a Principal in the NYC office of The Boston Consulting Group. He joined the firm in November 2005 as part of the Amsterdam office and transferred to the NYC office in February 2017. Between January 2013 and February 2014, Pieter was VP of Operations at ICHOM. He is a core member of BCGs Healthcare Practice Area and focuses primarily on the implications of Value Based Health Care at provider and payer systems, provider cost and quality transformations, and mergers. Pieter received his MBA from Kellogg School of Management, with majors in Strategy, Marketing, and Analytical Consulting. MSc in Theoretical Physics from University of Utrecht.

Trained as an ophthalmologist, Ward Bijlsma switched careers to health care management in 2012. Since then, he has worked as a manager in one of the largest training hospitals in the Netherlands where he was involved in value based healthcare implementation. In 2016 he switched to the insurance side to work on value based payment, in an effort to move from paying for volume to paying for value.

Ari Robicsek, M.D. is Chief Medical Analytics Officer at Providence St. Joseph Health, overseeing system-wide clinical analytics. He has led the development of Value Oriented Architecture, a platform using advanced analytical methods to surface key elements of care contributing to variation in cost and outcomes. Dr. Robicsek is an Infectious Diseases physician and Epidemiologist with research published in Nature Medicine and the Annals of Internal Medicine. He has presented at numerous national meetings, co-Chaired Epic's Research Advisory and Analytics Advisory Councils, and co-presents the American College of Healthcare Executives seminar on the strategic use of healthcare analytics.

Dr. Hess is a health services research of the Denver-Seattle Center of Innovation for Veteran-Centered and Value-Driven Care, a cardiologist at the VA Eastern Colorado Health Care System, and an Assistant Professor of Medicine at the University of Colorado. Using administrative, registry, and clinical trial data, he has explored the effectiveness and healthcare delivery of device therapy for patients with heart failure as well as treatment patterns, clinical outcomes, and novel therapies for patients with atrial fibrillation. Over the past two years, he has explored the concept of value in several areas, including the impact of cardiac procedural appropriateness as well as discharge processes on value.

Dr. Steven Schutzer is a Founding Member and Medical Director of the Connecticut Joint Replacement Institute and President of the Connecticut Joint Replacement Surgeons, LLC. Dr. Schutzer is also Physician Executive for the Orthopedic Service Line at Trinity Health – New England. Dr. Schutzer graduated with Honors from Union College and the University of Virginia School of Medicine and was a Lieutenant in the Medical Corps of the United States Navy. He was a Fellow in Adult Hip and Reconstructive Surgery at the Massachusetts General Hospital and an Instructor at the Harvard Medical School. Dr. Schutzer is a member of Orthopedic Associates of Hartford and is currently on the staff of Saint Francis Hospital, Hartford Hospital and the University of Connecticut John Dempsey Hospital. He is board certified by the American Board of Orthopedic Surgery.

Helen Burstin, is the Chief Scientific Officer of The National Quality Forum, a not-for-profit membership organization that works to catalyze healthcare improvement through quality measurement and reporting. Prior to joining NQF, Dr. Burstin was the Director of the Center for Primary Care, Prevention, and Clinical Partnerships at the Agency for Healthcare Research and Quality (AHRQ). Dr. Burstin is the author of more than 80 articles and book chapters on quality, safety and disparities. She is a Professorial Lecturer in the Department of Health Policy at George Washington University School of Public Health and a Clinical Associate Professor of Medicine at George Washington University where she serves as a preceptor in internal medicine.

Dr. Kate Goodrich joined the Centers for Medicare and Medicaid Services in September 2011 where she serves as the Director of the Center for Clinical Standards & Quality (CCSQ) and CMS Chief Medical Officer. This Center is responsible for over 20 quality measurement and value-based purchasing programs, implementation of the new Merit-based Incentive Payment System and the Improving Medicare Post-Acute Care Transformation Act, quality improvement programs in all 50 states, clinical standards and survey and certification of all providers across the nation, and all coverage decisions for treatments and services for CMS.

Sally Okun is the Vice President for Advocacy, Policy and Patient Safety at PatientsLikeMe. She is responsible for bringing patient voice and insight to diverse advocacy and health policy discussions at the national and global level, and is the company's liaison with external organizations, government and regulatory agencies. Since assuming the VP position in 2013 she's been actively involved in representing the patient perspective at numerous external activities including the inaugural PCORI Patient Engagement Advisory Panel; the Advisory Committee for the Reagan-Udall Foundation's Big Data for Patients (BD4P) program; the Scientific Advisory Committee for Innovation in Medical Evidence and Development (IMEDS); the Duke Margolis Center for Health Policy Real World Evidence Advisory Group. Sally is on the Strategic Planning Task Force for the American Heart Association Institute for Precision Cardiovascular Medicine, a member of the Leadership Consortium for a Value & Science-driven Health System at the National Academy of Medicine.

Dr. Stover is a health services researcher with expertise in developing and applying patient-reported outcomes (PROs). She is an assistant professor of Health Policy and Management at the University of North Carolina at Chapel Hill and a member of Lineberger Comprehensive Cancer Center. Her research focuses on three areas: 1) clinical benefits of using PRO measures (e.g., symptom questionnaires) during routine care delivery; 2) testing aggregated PROs as a potential quality of care metric at the practice level; and 3) barriers and facilitators to implementing PRO measures into routine care delivery. Dr. Stover serves as an investigator and co-investigator on several PCORI and NIH-funded studies. Dr. Stover was also one of the original developers of NIH's PROMIS measures. Her publications have been cited over 800 times.

Diane Bell is a recognized expert in using value and outcomes to transform healthcare, with first-hand experience of planning, launching and delivering outcomes-based contracts and advising on population-based systems of care across the National Health Service in England and in Europe. She has had a long NHS career, with roles as a practicing clinician, public health physician and as a board-level executive in several payer organizations. She has been lead director for large whole system redesigns, and is currently supporting clients to design and incentivize delivery of sustainable value-based care.

Dr. McConnell is the CEO Emeritus of Wake Forest University Medical Center, which is composed of an integrated healthcare system (Wake Forest Baptist Health), Wake Forest School of Medicine and Wake Forest Innovations. As CEO, he had the responsibility for the Medical Center's research, commercialization, education and patient care programs until May 2017. A urologist and translational research by training, Dr. McConnell's academic career has focused on patient-oriented-outcomes and evidence-based guidelines in prostate disease. He is a member of the National Academy of Medicine and currently works at Wake Forest to develop patient-relevant digital health solutions to improve the value of healthcare.

A biochemist by education, Michael Seewald built expertise in analytical disciplines (biophysics, bioinformatics, chemoinformatics) during his academic career, and authored/co-authored publications in leading journals such as Nature and EMBO Journal. Michael began his industry career in the area of bioinformatics, then moved through a number of positions of increasing responsibility in Finance, Strategy, Marketing, and Development. Since 2015, Michael is heading the Center of Excellence for Real World Evidence at Novartis.

Reed Siemieniuk is an internist based in Hamilton and Toronto, Canada. Reed has a focus on systematic reviews and clinical practice guideline methodology. He is the lead of the WikiRecs (Rapid Recommendations) initiative with the MAGIC Project, a non-profit research and innovation programme working to improve the creation, dissemination and dynamic updating of clinical practice guidelines, evidence summaries and decision aids [magicproject.org]. WikiRecs and the showcase project "BMJ Rapid Recommendations" aim to move evidence to practice by rapidly producing evidence summaries, trustworthy clinical practice recommendations, and decision aids.

Evelyn P. Whitlock is the Chief Science Officer at the Patient-Centered Outcomes Research Institute (PCORI). She oversees the organization's scientific activities and patient-centered comparative clinical effectiveness research agenda. Prior to joining PCORI, she spent almost 25 years conducting public domain research in affiliation with Kaiser Permanente, Northwest. Dr. Whitlock, a board-certified preventive medicine physician, was the founding Director of the Kaiser Permanente Research Affiliates Evidence-Based Practice Center and provided evidence synthesis services to the U.S. Preventive Services Task Force (USPSTF) for over 15 years before leaving to join PCORI.

Peter Tollman is a senior partner and managing director of BCG. Since joining the firm in 1989, Peter has held various leadership roles, including serving as global leader of BCG's Biopharmaceuticals practice, and as leader of the firm's People and Organization practice in the Americas. He is currently a BCG Fellow and a leader of BCG's CEO Advisory practice.

Over the course of his career, Peter has served many prominent firms around the globe on matters of leadership, strategy, and organizational and operational effectiveness. He was also founding managing director of a healthcare venture capital company, MPM Capital. In addition, he sits on the Board of Governors of the Jerusalem Academy of Music and Dance at the Hebrew University, and is a trustee of the Walnut Hill School for the Arts.